Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

Presidents/Donald J. Trump/Executive Order
Executive Order14357? Legally Debatable

Executive Order 14357—Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

Issued 2025-11-04 by Donald J. Trump

Plain-English Overview

AI-generated summary explaining what this action does, who it affects, and why it matters

This executive order is a response to concerns about the flow of synthetic opioids, particularly fentanyl, from China into the United States. The President determined that China had not taken sufficient action to stop this influx, posing a threat to national security and the economy. As a result, previous executive orders had imposed additional duties on goods coming from China.

Because the Chinese government has now agreed to take steps to reduce the flow of these drugs, including controlling exports of certain chemicals and stopping shipments to North America, this executive order lowers the existing duty rate from 20% to 10% on affected goods. This change will go into effect on November 10, 2025.

This action primarily affects businesses in the United States that import goods from China, particularly those involved in pharmaceutical ingredients and chemicals. It represents a shift in the relationship between the two countries regarding this specific issue, driven by China’s commitment to address the problem of fentanyl reaching the U.S.

AI-generated summary for educational purposes

Constitutional Analysis

How this action fits (or doesn't) within Article II authority and existing law

Executive Order 14357 ("Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China") imposes sanctions or economic restrictions targeting China. The President's stated rationale: "PRC to the United States constitutes an unusual and extraordinary threat to the national security, foreign policy, and economy of the United States that has its source in substantial part outside the United States." The International Emergency Economic Powers Act (IEEPA) grants the President broad authority to regulate international economic transactions when a national emergency has been declared. Presidents from both parties have used IEEPA extensively for foreign policy sanctions.

While the statutory authority is well-established, IEEPA's breadth has drawn constitutional criticism. The statute delegates sweeping power to the President during emergencies that can last for years or decades. The non-delegation doctrine questions whether Congress can transfer such broad economic regulatory authority to the executive branch. Despite these concerns, courts have generally deferred to presidential sanctions decisions.

Official Summary

DCPD202501092 * {margin:0; padding:0; text-indent:0; } .s1 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 12pt; } h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; } .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; margin:0pt; } .s2 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 11pt; } .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; } .s4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; } li {display: block; } #l1 {padding-left: 0pt;counter-reset: c1 1; } #l1> li>*:first-child:before {counter-increment: c1; content: "("counter(c1, lower-roman)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; } #l1> li:first-child>*:first-child:before {counter-increment: c1 0; } li {display: block; } #l2 {padding-left: 0pt;counter-reset: d1 2; } #l2> li>*:first-child:before {counter-increment: d1; content: "("counter(d1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; } #l2> li:first-child>*:first-child:before {counte

Read the official documentOpen on GovInfo →